Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Frontiers in Neurology

• Publication date

  2017-09-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.3389/fneur.2017.00503PMID 28993754PMCID 5622302
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease

  2017cited by this paper
• The Relationship Between Copper, Iron, and Selenium Levels and Alzheimer Disease

  2017cited by this paper
• Multifactorial Analysis of a Biomarker Pool for Alzheimer Disease Risk in a North Indian Population

  2017cited by this paper
• Measurements of serum non-ceruloplasmin copper by a direct fluorescent method specific to Cu(II)

  2017cited by this paper
• Characterization of plasma metal profiles in Alzheimer’s disease using multivariate statistical analysis

  2017cited by this paper
• Patients with Increased Non-Ceruloplasmin Copper Appear a Distinct Sub-Group of Alzheimer's Disease: A Neuroimaging Study.

  2017cited by this paper
• In Vivo Modeling of the Pathogenic Effect of Copper Transporter Mutations That Cause Menkes and Wilson Diseases, Motor Neuropathy, and Susceptibility to Alzheimer's Disease*

  2017cited by this paper
• Alzheimer’s disease: How metal ions define β-amyloid function

  2017cited by this paper
• Oxidative Stress Markers and Metal Ions are Correlated With Cognitive Function in Alzheimer’s Disease

  2017cited by this paper
• Non-ceruloplasmin bound copper and ATP7B gene variants in Alzheimer's disease.

  2016cited by this paper
• Distinctive Pattern of Serum Elements During the Progression of Alzheimer’s Disease

  2016cited by this paper
• Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls.

  2016cited by this paper
• Erratum to: Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer’s Disease: a Genetic Study of ATP7B Frequency

  2016cited by this paper
• Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer’s Disease

  2016cited by this paper
• Non-Ceruloplasmin Copper Distinguishes A Distinct Subtype of Alzheimer's Disease: A Study of EEG-Derived Brain Activity.

  2016cited by this paper
• Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer’s Disease: a Genetic Study of ATP7B Frequency

  2015cited by this paper
• Wilson's disease and other neurological copper disorders.

  2015cited by this paper
• Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer’s Disease: A Replication Study and Meta-Analyses

  2015cited by this paper
• Paradigm shift redefining molecular, metabolic and structural events in Alzheimer's disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration.

  2015cited by this paper
• A comparison of hair and serum trace elements in patients with Alzheimer disease and healthy participants.

  2015cited by this paper
• Estrogen Intake and Copper Depositions: Implications for Alzheimer's Disease?

  2014cited by this paper
• Age-Associated Changes of Brain Copper, Iron, and Zinc in Alzheimer's Disease and Dementia with Lewy Bodies

  2014cited by this paper
• an update on

  2014cited by this paper
• Meta-Analysis of Serum Non-Ceruloplasmin Copper in Alzheimer's Disease

  2013cited by this paper
• Elevated labile Cu is associated with oxidative pathology in Alzheimer disease.

  2012cited by this paper
• Aluminium, iron and copper in human brain tissues donated to the Medical Research Council's Cognitive Function and Ageing Study.

  2012cited by this paper
• Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease

  2012cited by this paper
• Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion.

  2011cited by this paper
• Paradigm Shift in Treatment of Alzheimer's Disease: Zinc Therapy Now a Conscientious Choice for Care of Individual Patients

  2011cited by this paper
• Re‐evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease

  2010cited by this paper
• Diagnosis and treatment of Wilson disease: An update

  2008cited by this paper
• The amyloid cascade hypothesis

  2008cited by this paper
• Therapeutics for Alzheimer’s disease based on the metal hypothesis

  2008cited by this paper
• Effects of copper metabolism on neurological functions in Wistar and Wilson's disease model rats.

  2006cited by this paper
• Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective?

  2005cited by this paper
• Amyloid‐β in Alzheimer's disease: the horse or the cart? Pathogenic or protective?

  2005cited by this paper
• d‐penicillamine reduces serum oxidative stress in Alzheimer’s disease patients

  2002cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Wilson's Disease.

  1991cited by this paper

• Copper homeostasis and cuproptosis in Alzheimer's disease (Review)

  2025cites this paper
• Synthesis and bio-activities of bifunctional tetrahydrosalen Cu (II) chelators with potential efficacy in Alzheimer's disease therapy.

  2024cites this paper
• Biometals in Alzheimer disease: emerging therapeutic and diagnostic potential of molybdenum and iodine

  2023cites this paper
• Role of Metal Cations of Copper, Iron, and Aluminum and Multifunctional Ligands in Alzheimer’s Disease: Experimental and Computational Insights

  2023cites this paper
• Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.

  2022cites this paper
• Chelation Combination—A Strategy to Mitigate the Neurotoxicity of Manganese, Iron, and Copper?

  2022cites this paper
• Do glutathione and copper interact to modify Alzheimer's disease pathogenesis?

  2022cites this paper
• α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer’s Disease

  2021cites this paper
• Research progress of adsorption and removal of heavy metals by chitosan and its derivatives: A review.

  2021cites this paper
• A Water-Soluble Peptoid Chelator that Can Remove Cu2+ from Amyloid-β and Stop the Formation of Reactive Oxygen Species Associated with Alzheimer's Disease.

  2021cites this paper
• An innovative colorimetric platform for the low-cost and selective identification of Cu(II), Fe(III), and Hg(II) using GQDs-DPA supported amino acids by microfluidic paper-based (µPADs) device: Multicolor plasmonic patterns

  2021cites this paper
• Efficient and portable cellulose-based colorimetric test paper for metal ion detection.

  2021cites this paper
• Current Biomedical Use of Copper Chelation Therapy

  2020cites this paper
• A Preliminary Study of Cu Exposure Effects upon Alzheimer’s Amyloid Pathology

  2020cites this paper
• Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches

  2020cites this paper
• Biomedical applications of copper ionophores

  2020cites this paper
• X-ray Absorption Spectroscopy Investigations of Copper(II) Coordination in the Human Amyloid β Peptide.

  2019cites this paper
• Targeting metals rescues the phenotype in an animal model of tauopathy.

  2018cites this paper
• Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals

  2018cites this paper
• Aroylhydrazones constitute a promising class of ‘metal-protein attenuating compounds’ for the treatment of Alzheimer’s disease: a proof-of-concept based on the study of the interactions between zinc(II) and pyridine-2-carboxaldehyde isonicotinoyl hydrazone

  2018cites this paper
• Serum Copper is not Altered in Frontotemporal Lobar Degeneration

  2018cites this paper
• Simple and mixed complexes of copper(II) with 8-hydroxyquinoline derivatives and amino acids: Characterization in solution and potential biological implications.

  2018cites this paper
• Copper signalling: causes and consequences

  2018cites this paper